258 research outputs found
Influence of the Constitutive Model for Shotcrete on the Predicted Structural Behavior of the Shotcrete Shell of a Deep Tunnel
The aim of the present paper is to investigate the influence of the constitutive model for shotcrete on the predicted displacements and stresses in shotcrete shells of deep tunnels. Previously proposed shotcrete models as well as a new extended damage plasticity model for shotcrete are evaluated in the context of 2D finite element simulations of the excavation of a stretch of a deep tunnel by means of the New Austrian Tunneling Method. Thereby, the behavior of the surrounding rock mass is described by the commonly used HoekBrown model. Differences in predicted evolutions of displacements and stresses in the shotcrete shell, resulting from the different shotcrete models, are discussed and simulation results are compared to available in situ measurement data.(VLID)3044916Version of recor
Drought affects the heat-hardening capacity of alpine plants as indicated by changes in xanthophyll cycle pigments, singlet oxygen scavenging, α-tocopherol and plant hormones
AbstractAlpine environments in Europe are increasingly affected by more erratic precipitation patterns, and more frequent drought and heat waves. Heat-hardening capacity is a key feature for survival of these abiotic stress factors, but it is poorly understood how heat and drought affect plant performance when combined. The main objectives of this study were (1) to determine maximum heat hardening capacity in 14 selected plant species and (2) to study how alpine plants respond to combined heat and drought stress compared to heat alone. (3) For risk assessment maximum leaf temperatures were measured in the field and (4) important methodological aspects of testing heat tolerance were evaluated. Heat hardening capacity was assessed by Tc, the heat threshold of photosystem II (PS II), and by heat tolerance tests based on visual inspection of leaf tissue damage or potential quantum efficiency of PS II (Fv/Fm). A purpose-built Heat Tolerance Testing System (HTTS) was used, which allows for controlled heat exposure of whole plants under nearly natural conditions. Additionally, in two species from contrasting habitats, Senecio incanus and Primula minima, the dynamics of heat hardening was studied during and after 8days exposure to heat (H), or to a combination of heat and severe drought (H+D) within a light-transmissive heat hardening chamber at the alpine field site. In both species, H treatment significantly increased heat tolerance (LT50), determined by the HTTS, to 58.0°C and 54.9°C, respectively, and was accompanied by elevated production of abscisic acid (ABA) and salicylic acid (SA), whereas jasmonic acid (JA) levels decreased. Under H+D the LT50 was only 56.5°C and 51.6°C, respectively, and levels of ABA were higher in S. incanus and SA lower in both species in comparison to H. Changes in xanthophyll cycle pigments, α-tocopherol and carotenoids:chlorophyll ratio were more pronounced in P. minima than in S. incanus. In P. minima both H and H+D significantly increased singlet oxygen (1O2) scavenging capacity, determined by electron paramagnetic resonance spectroscopy (EPR). In the field, the maximum half-hourly mean (HHM) leaf temperature of P. minima (32.2°C) was significantly lower than of S. incanus (46.5°C, a potentially harmful temperature). We conclude that the investigated species are well adapted to the prevailing temperature conditions in the field. They also possess an outstanding heat hardening capacity, but this can be curtailed when heat is combined with drought. As drought further increases leaf temperatures, the risk of suffering lethal heat damage of some species may increase in the future, particularly at south exposed, ruderal alpine sites with uncertain water supply
Synergies between Surface Microstructuring and Molecular Nanopatterning for Controlling Cell Populations on Polymeric Biointerfaces
Ergebnisorientierte Massnahmen zur Förderung der Biodiversität in der Berglandwirtschaft - Ein Handbuch für die Politik
Das Handbuch enthält:
- Eine Einführung in ergebnisorientierte Massnahmen Projekt MERIT
- Einen Überblick über die Vor- und Nachteile ergebnisorientierte Massnahmen
- Wissenschaftlich fundierte Empfehlungen für die Gestaltung, Umsetzung und Governance ergebnisorientierter Biodiversitätsfördermassnahmen in der Berglandwirtschaft
- Beispiel von ergebnisorientierten Massnahmen in Europ
Result-oriented Measures for Biodiversity in Mountain Farming - A Policy Handbook
The handbook includes:
- An introduction to result-oriented measures
- An overview of the advantages and disadvantages of result-oriented measures
- Specific recommendations for the design, implementation and governance of resultoriented
measures for biodiversity in mountain farming
- Examples of result-oriented measures that have been implemente
Randomized controlled phase 2 trial of hydroxychloroquine in childhood interstitial lung disease
Background
No results of controlled trials are available for any of the few treatments offered to children with interstitial lung diseases (chILD). We evaluated hydroxychloroquine (HCQ) in a phase 2, prospective, multicentre, 1:1-randomized, double-blind, placebo-controlled, parallel-group/crossover trial. HCQ (START arm) or placebo were given for 4 weeks. Then all subjects received HCQ for another 4 weeks. In the STOP arm subjects already taking HCQ were randomized to 12 weeks of HCQ or placebo (= withdrawal of HCQ). Then all subjects stopped treatment and were observed for another 12 weeks.
Results
26 subjects were included in the START arm, 9 in the STOP arm, of these four subjects participated in both arms. The primary endpoint, presence or absence of a response to treatment, assessed as oxygenation (calculated from a change in transcutaneous O 2 -saturation of ≥ 5%, respiratory rate ≥ 20% or level of respiratory support), did not differ between placebo and HCQ groups. Secondary endpoints including change of O 2 -saturation ≥ 3%, health related quality of life, pulmonary function and 6-min-walk-test distance, were not different between groups. Finally combining all placebo and all HCQ treatment periods did not identify significant treatment effects. Overall effect sizes were small. HCQ was well tolerated, adverse events were not different between placebo and HCQ.
Conclusions
Acknowledging important shortcomings of the study, including a small study population, the treatment duration, lack of outcomes like lung function testing below age of 6 years, the small effect size of HCQ treatment observed requires careful reassessments of prescriptions in everyday practice (EudraCT-Nr.: 2013-003714-40, www.clinicaltrialsregister.eu , registered 02.07.2013)
The Swiss Approach - feasibility of a national low-dose CT lung cancer screening program.
BACKGROUND
Lung cancer is the leading cause of cancer-related deaths in Switzerland. Despite this, there is no lung cancer screening program in the country. In the United States, low-dose computed tomography (LDCT) lung cancer screening is partially established and endorsed by guidelines. Moreover, evidence is growing that screening reduces lung cancer-related mortality and this was recently shown in a large European randomized controlled trial. Implementation of a lung cancer screening program, however, is challenging and depends on many country-specific factors. The goal of this article is to outline a potential Swiss lung cancer screening program.
FRAMEWORK
An exhaustive literature review on international screening models as well as interviews and site visits with international experts were initiated. Furthermore, workshops and interviews with national experts and stakeholders were conducted to share experiences and to establish the basis for a national Swiss lung cancer screening program.
SCREENING APPROACH
General practitioners, pulmonologists and the media should be part of the recruitment process. Decentralisation of the screening might lead to a higher adherence rate. To reduce stigmatisation, the screening should be integrated in a "lung health check". Standardisation and a common quality level are mandatory. The PLCOm2012 risk calculation model with a threshold of 1.5% risk for developing cancer in the next six years should be used in addition to established inclusion criteria. Biennial screening is preferred. LUNG RADS and NELSON+ are applied as classification models for lung nodules.
CONCLUSION
Based on data from recent studies, literature research, a health technology assessment, the information gained from this project and a pilot study the Swiss Interest Group for lung cancer screening (CH-LSIG) recommends the timely introduction of a systematic lung cancer screening program in Switzerland. The final decision is for the Swiss Cancer Screening Committee to make
The Swiss Approach - feasibility of a national low-dose CT lung cancer screening program
BACKGROUND
Lung cancer is the leading cause of cancer-related deaths in Switzerland. Despite this, there is no lung cancer screening program in the country. In the United States, low-dose computed tomography (LDCT) lung cancer screening is partially established and endorsed by guidelines. Moreover, evidence is growing that screening reduces lung cancer-related mortality and this was recently shown in a large European randomized controlled trial. Implementation of a lung cancer screening program, however, is challenging and depends on many country-specific factors. The goal of this article is to outline a potential Swiss lung cancer screening program.
FRAMEWORK
An exhaustive literature review on international screening models as well as interviews and site visits with international experts were initiated. Furthermore, workshops and interviews with national experts and stakeholders were conducted to share experiences and to establish the basis for a national Swiss lung cancer screening program.
SCREENING APPROACH
General practitioners, pulmonologists and the media should be part of the recruitment process. Decentralisation of the screening might lead to a higher adherence rate. To reduce stigmatisation, the screening should be integrated in a "lung health check". Standardisation and a common quality level are mandatory. The PLCOm2012 risk calculation model with a threshold of 1.5% risk for developing cancer in the next six years should be used in addition to established inclusion criteria. Biennial screening is preferred. LUNG RADS and NELSON+ are applied as classification models for lung nodules.
CONCLUSION
Based on data from recent studies, literature research, a health technology assessment, the information gained from this project and a pilot study the Swiss Interest Group for lung cancer screening (CH-LSIG) recommends the timely introduction of a systematic lung cancer screening program in Switzerland. The final decision is for the Swiss Cancer Screening Committee to make
Hypertrophic cardiomyopathy is characterized by alterations of the mitochondrial calcium uniporter complex proteins: insights from patients with aortic valve stenosis versus hypertrophic obstructive cardiomyopathy
Introduction: Hypertrophies of the cardiac septum are caused either by aortic valve stenosis (AVS) or by congenital hypertrophic obstructive cardiomyopathy (HOCM). As they induce cardiac remodeling, these cardiac pathologies may promote an arrhythmogenic substrate with associated malignant ventricular arrhythmias and may lead to heart failure. While altered calcium (Ca2+) handling seems to be a key player in the pathogenesis, the role of mitochondrial calcium handling was not investigated in these patients to date.Methods: To investigate this issue, cardiac septal samples were collected from patients undergoing myectomy during cardiac surgery for excessive septal hypertrophy and/or aortic valve replacement, caused by AVS and HOCM. Septal specimens were matched with cardiac tissue obtained from post-mortem controls without cardiac diseases (Ctrl).Results and discussion: Patient characteristics and most of the echocardiographic parameters did not differ between AVS and HOCM. Most notably, the interventricular septum thickness, diastolic (IVSd), was the greatest in HOCM patients. Histological and molecular analyses showed a trend towards higher fibrotic burden in both pathologies, when compared to Ctrl. Most notably, the mitochondrial Ca2+ uniporter (MCU) complex associated proteins were altered in both pathologies of left ventricular hypertrophy (LVH). On the one hand, the expression pattern of the MCU complex subunits MCU and MICU1 were shown to be markedly increased, especially in AVS. On the other hand, PRMT-1, UCP-2, and UCP-3 declined with hypertrophy. These conditions were associated with an increase in the expression patterns of the Ca2+ uptaking ion channel SERCA2a in AVS (p = 0.0013), though not in HOCM, compared to healthy tissue. Our data obtained from human specimen from AVS or HOCM indicates major alterations in the expression of the mitochondrial calcium uniporter complex and associated proteins. Thus, in cardiac septal hypertrophies, besides modifications of cytosolic calcium handling, impaired mitochondrial uptake might be a key player in disease progression
International management platform for children's interstitial lung disease (chILD-EU)
BACKGROUND: Children's interstitial lung diseases (chILD) cover many rare entities, frequently not diagnosed or studied in detail. There is a great need for specialised advice and for internationally agreed subclassification of entities collected in a register.Our objective was to implement an international management platform with independent multidisciplinary review of cases at presentation for long-term follow-up and to test if this would allow for more accurate diagnosis. Also, quality and reproducibility of a diagnostic subclassification system were assessed using a collection of 25 complex chILD cases. METHODS: A web-based chILD management platform with a registry and biobank was successfully designed and implemented. RESULTS: Over a 3-year period, 575 patients were included for observation spanning a wide spectrum of chILD. In 346 patients, multidisciplinary reviews were completed by teams at five international sites (Munich 51%, London 12%, Hannover 31%, Ankara 1% and Paris 5%). In 13%, the diagnosis reached by the referring team was not confirmed by peer review. Among these, the diagnosis initially given was wrong (27%), imprecise (50%) or significant information was added (23%).The ability of nine expert clinicians to subcategorise the final diagnosis into the chILD-EU register classification had an overall exact inter-rater agreement of 59% on first assessment and after training, 64%. Only 10% of the 'wrong' answers resulted in allocation to an incorrect category. Subcategorisation proved useful but training is needed for optimal implementation. CONCLUSIONS: We have shown that chILD-EU has generated a platform to help the clinical assessment of chILD. TRIAL REGISTRATION NUMBER: Results, NCT02852928
- …